Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis

BACKGROUND: In several countries, extended interval COVID-19 vaccination regimens are now used to accelerate population coverage, but the relative immunogenicity of different vaccines in older people remains uncertain. In this study we aimed to assess the antibody and cellular responses of older peo...

Descripción completa

Detalles Bibliográficos
Autores principales: Parry, Helen, Bruton, Rachel, Tut, Gokhan, Ali, Myah, Stephens, Christine, Greenwood, David, Faustini, Sian, Hughes, Sam, Huissoon, Aarnoud, Meade, Rory, Brown, Kevin, Amirthalingam, Gayatri, Otter, Ashley, Hallis, Bassam, Richter, Alex, Zuo, Jianmin, Moss, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357462/
https://www.ncbi.nlm.nih.gov/pubmed/34401865
http://dx.doi.org/10.1016/S2666-7568(21)00169-0

Ejemplares similares

Ejemplares similares